Trials / Completed
CompletedNCT01541293
Intrauterine Lidocaine for Laminaria
Intrauterine Lidocaine for Pain Control During Laminaria Insertion Prior to Dilation & Evacuation (D&E)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- University of North Carolina, Chapel Hill · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to investigate whether instilling a small amount of liquid lidocaine into the uterus will decrease pain felt by women during laminaria insertions done for cervical dilation prior to second trimester abortion. The investigators hypothesize that women who receive intrauterine lidocaine in addition to a paracervical block will experience less pain than women who receive only a paracervical block.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine | 100mg of liquid lidocaine, single dose, instilled into the uterine cavity via a flexible trans-cervical catheter immediately prior to laminaria insertion. |
| DRUG | Normal Saline | 5mL of normal saline, instilled into the uterus via a flexible trans-cervical catheter immediately prior to laminaria insertion. |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2012-02-29
- Last updated
- 2014-05-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01541293. Inclusion in this directory is not an endorsement.